(3-((4-methylpiperidin-1-yl)methyl)phenyl)boronic acid

Catalog No. :
ACDEPX390
CAS No. :
1332746-94-7
Molecular Formula :
C13H20BNO2
Molecular Weight :
233.12

IUPAC Name:(3-((4-methylpiperidin-1-yl)methyl)phenyl)boronic acid

(3-((4-methylpiperidin-1-yl)methyl)phenyl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$281.00Login to see priceInquiryInquiry
1g95%$793.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3-((4-methylpiperidin-1-yl)methyl)phenyl)boronic acid
IUPAC Name(3-((4-methylpiperidin-1-yl)methyl)phenyl)boronic acid
MDL No.MFCD16198055
Molecular FormulaC13H20BNO2
Molecular Weight233.12
SMILESCC1CCN(CC2=CC(B(O)O)=CC=C2)CC1
InChI KeyZRHAQCWKPCJKML-UHFFFAOYSA-N
Synonym(3-((4-Methylpiperidin-1-yl)Methyl)phenyl)boronic acid;Boronic acid, B-[3-[(4-methyl-1-piperidinyl)methyl]phenyl]-;B-[3-[(4-Methyl-1-piperidinyl)methyl]phenyl]boronic acid
CAS No.1332746-94-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACDEPX390 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXZFJ430 route compound structure diagram
    ACXZFJ43087199-16-4 In Stock
  4. Then
  5. ACDEPX390 route product structure diagram
    ACDEPX3901332746-94-7
Inquiry

2. ACDEPX390 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXNHK580 route compound structure diagram
    ACXNHK58051323-43-4 In Stock
  4. Then
  5. ACDEPX390 route product structure diagram
    ACDEPX3901332746-94-7
Inquiry

Comments (0)